View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsOsmozis 배당 및 자사주 매입배당 기준 점검 0/6Osmozis 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-15.1%자사주 매입 수익률총 주주 수익률-15.1%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • Jun 11New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.6% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€43.0m market cap, or US$46.2m).New Risk • May 30New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 54% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks High level of debt (54% net debt to equity). Profit margins are more than 30% lower than last year (6.7% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€42.9m market cap, or US$46.4m).New Risk • May 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.5% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€42.3m market cap, or US$45.9m).Reported Earnings • Jan 02Full year 2023 earnings released: EPS: €0.29 (vs €0.47 in FY 2022)Full year 2023 results: EPS: €0.29 (down from €0.47 in FY 2022). Revenue: €13.2m (up 14% from FY 2022). Net income: €701.7k (down 30% from FY 2022). Profit margin: 5.3% (down from 8.7% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.New Risk • Dec 26New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended February 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (150% net debt to equity). Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Shareholders have been diluted in the past year (34% increase in shares outstanding). Market cap is less than US$100m (€31.4m market cap, or US$34.6m).공시 • Oct 13Osmozis SA (ENXTPA:ALOSM) acquired Campingconnect Ltd.Osmozis SA (ENXTPA:ALOSM) acquired Campingconnect Ltd on October 11, 2023.Osmozis SA (ENXTPA:ALOSM) completed the acquisition of Campingconnect Ltd on October 11, 2023.분석 기사 • Sep 16There's Been No Shortage Of Growth Recently For Osmozis' (EPA:ALOSM) Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...Reported Earnings • Dec 17Full year 2022 earnings releasedFull year 2022 results: Revenue: €11.6m (up 21% from FY 2021). Net income: €1.01m (up 1.7% from FY 2021). Profit margin: 8.7% (down from 10% in FY 2021). The decrease in margin was driven by higher expenses.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Assistant CEO, Director & Co-Founder Yves Boulot was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €7.64, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 21x in the Communications industry in France. Total loss to shareholders of 21% over the past three years.Price Target Changed • Apr 27Price target increased to €9.50Up from €8.30, the current price target is provided by 1 analyst. New target price is 18% above last closing price of €8.06. Stock is up 55% over the past year. The company is forecast to post earnings per share of €1.17 for next year compared to €0.46 last year.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Assistant CEO, Director & Co-Founder Yves Boulot was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.분석 기사 • Jan 24At €6.85, Is It Time To Put Osmozis SA (EPA:ALOSM) On Your Watch List?While Osmozis SA ( EPA:ALOSM ) might not be the most widely known stock at the moment, it received a lot of attention...Price Target Changed • Jan 14Price target increased to €9.50Up from €8.00, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €7.65. Stock is up 39% over the past year. The company is forecast to post earnings per share of €1.07 for next year compared to €0.46 last year.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 22% share price gain to €8.20, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 24x in the Communications industry in Europe. Total returns to shareholders of 10% over the past three years.분석 기사 • Dec 28Investors Shouldn't Be Too Comfortable With Osmozis' (EPA:ALOSM) Robust EarningsLast week's profit announcement from Osmozis SA ( EPA:ALOSM ) was underwhelming for investors, despite headline numbers...분석 기사 • Dec 25Is Osmozis (EPA:ALOSM) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Dec 24Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: €0.46 (up from €0.92 loss in FY 2020). Revenue: €10.0m (up 21% from FY 2020). Net income: €990.4k (up €2.96m from FY 2020). Profit margin: 9.9% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 22%, compared to a 21% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Reported Earnings • Dec 24Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: €0.46 (up from €0.92 loss in FY 2020). Revenue: €10.0m (up 21% from FY 2020). Net income: €990.4k (up €2.96m from FY 2020). Profit margin: 9.9% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 22%, compared to a 21% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Price Target Changed • Oct 13Price target increased to €8.00Up from €6.70, the current price target is provided by 1 analyst. New target price is 40% above last closing price of €5.70. Stock is up 6.5% over the past year.분석 기사 • Jun 13Is Osmozis (EPA:ALOSM) Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Reported Earnings • Jun 05First half 2021 earnings released: €0.22 loss per share (vs €0.52 loss in 1H 2020)The company reported a decent first half result with reduced losses and improved control over expenses, although revenues were flat. First half 2021 results: Revenue: €3.11m (flat on 1H 2020). Net loss: €479.0k (loss narrowed 57% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 14% per year.분석 기사 • Feb 28How Is Osmozis' (EPA:ALOSM) CEO Paid Relative To Peers?Gérard Tremblay has been the CEO of Osmozis SA ( EPA:ALOSM ) since 2016, and this article will examine the executive's...분석 기사 • Jan 05Is Osmozis (EPA:ALOSM) Likely To Turn Things Around?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Is New 90 Day High Low • Dec 31New 90-day high: €6.50The company is up 19% from its price of €5.45 on 02 October 2020. The French market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 8.0% over the same period.Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 15% share price gain to €6.50, the stock is trading at a trailing P/E ratio of 40.1x, up from the previous P/E ratio of 34.8x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 19%.Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 20% share price gain to €5.75, the stock is trading at a trailing P/E ratio of 35.4x, up from the previous P/E ratio of 29.6x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 36%.Valuation Update With 7 Day Price Move • Oct 19Market pulls back on stock over the past weekAfter last week's 16% share price decline to €5.05, the stock is trading at a trailing P/E ratio of 31.1x, down from the previous P/E ratio of 37x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 45%.Is New 90 Day High Low • Oct 19New 90-day low: €5.05The company is down 27% from its price of €6.95 on 21 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 11% over the same period.Is New 90 Day High Low • Sep 23New 90-day low: €5.30The company is down 28% from its price of €7.35 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 18% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 ALOSM 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: ALOSM 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Osmozis 배당 수익률 vs 시장ALOSM의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ALOSM)n/a시장 하위 25% (FR)2.0%시장 상위 25% (FR)5.7%업계 평균 (Communications)1.5%분석가 예측 (ALOSM) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 ALOSM 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 ALOSM 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 ALOSM 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: ALOSM 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YFR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/08/12 18:13종가2024/08/12 00:00수익2024/02/29연간 수익2023/08/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Osmozis SA는 3명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Christian DevismesCIC Market Solutions (ESN)Thomas CoudryStifel, formerly Bryan GarnierEric LemarieStifel, formerly Bryan Garnier
New Risk • Jun 11New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.6% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€43.0m market cap, or US$46.2m).
New Risk • May 30New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 54% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks High level of debt (54% net debt to equity). Profit margins are more than 30% lower than last year (6.7% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€42.9m market cap, or US$46.4m).
New Risk • May 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.5% net profit margin). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (€42.3m market cap, or US$45.9m).
Reported Earnings • Jan 02Full year 2023 earnings released: EPS: €0.29 (vs €0.47 in FY 2022)Full year 2023 results: EPS: €0.29 (down from €0.47 in FY 2022). Revenue: €13.2m (up 14% from FY 2022). Net income: €701.7k (down 30% from FY 2022). Profit margin: 5.3% (down from 8.7% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
New Risk • Dec 26New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended February 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (150% net debt to equity). Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Shareholders have been diluted in the past year (34% increase in shares outstanding). Market cap is less than US$100m (€31.4m market cap, or US$34.6m).
공시 • Oct 13Osmozis SA (ENXTPA:ALOSM) acquired Campingconnect Ltd.Osmozis SA (ENXTPA:ALOSM) acquired Campingconnect Ltd on October 11, 2023.Osmozis SA (ENXTPA:ALOSM) completed the acquisition of Campingconnect Ltd on October 11, 2023.
분석 기사 • Sep 16There's Been No Shortage Of Growth Recently For Osmozis' (EPA:ALOSM) Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
Reported Earnings • Dec 17Full year 2022 earnings releasedFull year 2022 results: Revenue: €11.6m (up 21% from FY 2021). Net income: €1.01m (up 1.7% from FY 2021). Profit margin: 8.7% (down from 10% in FY 2021). The decrease in margin was driven by higher expenses.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Assistant CEO, Director & Co-Founder Yves Boulot was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €7.64, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 21x in the Communications industry in France. Total loss to shareholders of 21% over the past three years.
Price Target Changed • Apr 27Price target increased to €9.50Up from €8.30, the current price target is provided by 1 analyst. New target price is 18% above last closing price of €8.06. Stock is up 55% over the past year. The company is forecast to post earnings per share of €1.17 for next year compared to €0.46 last year.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Assistant CEO, Director & Co-Founder Yves Boulot was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
분석 기사 • Jan 24At €6.85, Is It Time To Put Osmozis SA (EPA:ALOSM) On Your Watch List?While Osmozis SA ( EPA:ALOSM ) might not be the most widely known stock at the moment, it received a lot of attention...
Price Target Changed • Jan 14Price target increased to €9.50Up from €8.00, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €7.65. Stock is up 39% over the past year. The company is forecast to post earnings per share of €1.07 for next year compared to €0.46 last year.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 22% share price gain to €8.20, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 24x in the Communications industry in Europe. Total returns to shareholders of 10% over the past three years.
분석 기사 • Dec 28Investors Shouldn't Be Too Comfortable With Osmozis' (EPA:ALOSM) Robust EarningsLast week's profit announcement from Osmozis SA ( EPA:ALOSM ) was underwhelming for investors, despite headline numbers...
분석 기사 • Dec 25Is Osmozis (EPA:ALOSM) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Dec 24Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: €0.46 (up from €0.92 loss in FY 2020). Revenue: €10.0m (up 21% from FY 2020). Net income: €990.4k (up €2.96m from FY 2020). Profit margin: 9.9% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 22%, compared to a 21% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Reported Earnings • Dec 24Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: €0.46 (up from €0.92 loss in FY 2020). Revenue: €10.0m (up 21% from FY 2020). Net income: €990.4k (up €2.96m from FY 2020). Profit margin: 9.9% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 22%, compared to a 21% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Price Target Changed • Oct 13Price target increased to €8.00Up from €6.70, the current price target is provided by 1 analyst. New target price is 40% above last closing price of €5.70. Stock is up 6.5% over the past year.
분석 기사 • Jun 13Is Osmozis (EPA:ALOSM) Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Reported Earnings • Jun 05First half 2021 earnings released: €0.22 loss per share (vs €0.52 loss in 1H 2020)The company reported a decent first half result with reduced losses and improved control over expenses, although revenues were flat. First half 2021 results: Revenue: €3.11m (flat on 1H 2020). Net loss: €479.0k (loss narrowed 57% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 14% per year.
분석 기사 • Feb 28How Is Osmozis' (EPA:ALOSM) CEO Paid Relative To Peers?Gérard Tremblay has been the CEO of Osmozis SA ( EPA:ALOSM ) since 2016, and this article will examine the executive's...
분석 기사 • Jan 05Is Osmozis (EPA:ALOSM) Likely To Turn Things Around?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Is New 90 Day High Low • Dec 31New 90-day high: €6.50The company is up 19% from its price of €5.45 on 02 October 2020. The French market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 8.0% over the same period.
Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 15% share price gain to €6.50, the stock is trading at a trailing P/E ratio of 40.1x, up from the previous P/E ratio of 34.8x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 19%.
Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 20% share price gain to €5.75, the stock is trading at a trailing P/E ratio of 35.4x, up from the previous P/E ratio of 29.6x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 36%.
Valuation Update With 7 Day Price Move • Oct 19Market pulls back on stock over the past weekAfter last week's 16% share price decline to €5.05, the stock is trading at a trailing P/E ratio of 31.1x, down from the previous P/E ratio of 37x. This compares to an average P/E of 34x in the Communications industry in France. Total return to shareholders over the past three years is a loss of 45%.
Is New 90 Day High Low • Oct 19New 90-day low: €5.05The company is down 27% from its price of €6.95 on 21 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 11% over the same period.
Is New 90 Day High Low • Sep 23New 90-day low: €5.30The company is down 28% from its price of €7.35 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 18% over the same period.